UPDATE 1-Lilly's psoriatic arthritis drug succeeds in late-stage study
April 20, 2015 at 08:45 AM EDT
April 20 (Reuters) - Eli Lilly and Co said its experimental drug, ixekizumab, reduced the signs and symptoms of active psoriatic arthritis in patients more than a placebo did in a late-stage trial.